|
Dubermatinib
|
TP-0903
|
1341200-45-0
|
|
S49076
|
CS-2684
|
1265965-22-7
|
|
PRT-060318
|
PRT-060318
|
1194961-19-7
|
|
Alectinib Hydrochloride
|
艾乐替尼盐酸盐
|
1256589-74-8
|
|
Src Inhibitor 3
|
Src Inhibitor 3
|
2380027-49-4
|
|
(Rac)-IBT6A
|
1412418-47-3
|
1412418-47-3
|
|
Fostamatinib
|
福他替尼
|
901119-35-5
|
|
Fostamatinib disodium hexahydrate
|
福他替尼钠盐水合物
|
914295-16-2
|
|
Cediranib maleate
|
西地尼布马来酸盐
|
857036-77-2
|
|
Taletrectinib
|
DS-6051b
|
1505515-69-4
|
|
BIIB068
|
BIIB068
|
1798787-27-5
|
|
VEGFR-2-IN-6
|
帕唑帕尼杂质3
|
444731-47-9
|
|
NVP-BHG712 isomer
|
NVP-BHG712 isomer
|
2245892-85-5
|
|
Imatinib D4
|
[2H4]-伊马替尼
|
1134803-16-9
|
|
AG-13958
|
N-[2-氟-5-[[3-[(1E)-2-(2-吡啶基)乙烯基]-1H-吲唑-6-基]氨基]苯基]-1,3-二甲基-1H-吡唑-5-甲酰胺
|
319460-94-1
|
|
TAK-593
|
1005780-62-0
|
1005780-62-0
|
|
Tyrphostin A9
|
酪氨酸磷酸化抑制剂A9
|
10537-47-0
|
|
Merestinib dihydrochloride
|
N-[3-氟-4-[[1-甲基-6-(1H-吡唑-4-基)-1H-吲唑-5-基]氧基]苯基]-1-(4-氟苯基)-1,2-二氢-6-甲基-2-氧代-3-吡啶甲酰胺二盐酸盐
|
1206801-37-7
|
|
Ceritinib dihydrochloride
|
双盐酸盐色瑞替尼
|
1380575-43-8
|
|
GZD824
|
GZD824
|
1257628-77-5
|
|
GZD824 dimesylate
|
GZD824DIMESYLATE
|
1421783-64-3
|
|
c-Met inhibitor 1
|
3-[(2-甲基-2H-吲唑-5-基)硫基]-6-(1-甲基-1H-吡唑-4-基)-1,2,4-三唑并[4,3-B]哒嗪
|
1357072-61-7
|
|
A 419259 trihydrochloride
|
7-[反式-4-(4-甲基-1-哌嗪基)环己基]-5-(4-苯氧基苯基)-7H-吡咯并[2,3-D]嘧啶-4-胺三盐酸盐
|
1435934-25-0
|
|
Tirabrutinib
|
替拉鲁替尼
|
1351636-18-4
|
|
CEP-37440
|
CEP-37440
|
1391712-60-9
|
|
AMG 925
|
AMG-925
|
1401033-86-0
|
|
H-89
|
N-[2-[P-溴苯丙烯盐基氨基]乙基]-5-异喹啉磺酰胺
|
127243-85-0
|
|
BIBF 1202
|
BIBF 1202
|
894783-71-2
|
|
Ilorasertib hydrochloride
|
ILORASERTIB HYDROCHLORIDE (ABT-348 HYDROCHLORIDE)
|
1847485-91-9
|
|
EOC317
|
ACTB-1003
|
939805-30-8
|
|
JI-101
|
JI-101
|
900573-88-8
|
|
Pexidartinib hydrochloride
|
培西达替尼盐酸盐
|
2040295-03-0
|
|
CCT241736
|
CS-2683
|
1402709-93-6
|
|
SYN1143
|
N-[3-氟-4-[(7-甲氧基喹啉-4-基)氧基]苯基]-1-(2-羟基-2-甲基丙基)-5-甲基-3-氧代-2-苯基-2,3-二氢-1H-吡唑-4-甲酰胺
|
913376-84-8
|
|
PP58
|
Pyrido[2,3-d]pyrimidin-7(8H)-one,2-[[4-(2-aminoethoxy)phenyl]amino]-6-(2,6-dichlorophenyl)-8-methyl-
|
212391-58-7
|
|
VEGFR-2-IN-5
|
N2-[4-[(3-氨基丙基)氨基]苯基]-N4-(5-环丙基-1H-吡唑-3-基)-2,4-嘧啶二胺
|
1430089-64-7
|
|
SCR-1481B1
|
麦他替尼胺丁三醇
|
1174161-86-4
|
|
Indirubin Derivative E804
|
Indirubin Derivative E804
|
854171-35-0
|
|
c-Fms-IN-2
|
791587-67-2
|
791587-67-2
|
|
c-Fms-IN-1
|
C-FMS-IN-1
|
885703-64-0
|
|
BBT594
|
BBT594
|
882405-89-2
|
|
CCG215022
|
CCG215022
|
1813527-81-9
|
|
NAMI-A
|
201653-76-1
|
201653-76-1
|
|
NVP-ACC789
|
N-(3-溴-4-甲基苯基)-4-(4-吡啶甲基)-1-酞嗪胺
|
300842-64-2
|
|
Glesatinib hydrochloride
|
CS-2642
|
1123838-51-6
|
|
ASP5878
|
ASP-5878
|
1453208-66-6
|
|
Linifanib
|
利尼伐尼
|
796967-16-3
|
|
Crizotinib hydrochloride
|
克里唑替尼盐酸
|
1415560-69-8
|
|
Ibrutinib deacryloylpiperidine
|
伊布替尼中间体N-2
|
330786-24-8
|
|
BMX-IN-1
|
N-[2-甲基-5-[9-[4-[(甲基磺酰基)氨基]苯基]-2-氧代苯并[H]-1,6-萘啶-1(2H)-基]苯基]-2-丙烯酰胺
|
1431525-23-3
|
|
QL47
|
1469988-75-7
|
1469988-75-7
|
|
Trapidil
|
乐可安
|
15421-84-8
|
|
Metadoxine
|
美他多辛
|
74536-44-0
|
|
Tanshinone IIA
|
丹参酮 IIA
|
568-72-9
|
|
Formononetin
|
刺芒柄花素
|
485-72-3
|
|
Scutellarein
|
野黄芩素
|
529-53-3
|
|
Fangchinoline
|
防己诺林碱
|
436-77-1
|
|
Bilobetin
|
7-去甲基银杏双黄酮
|
521-32-4
|
|
7-Hydroxy-4-chromone
|
7-羟基色原酮
|
59887-89-7
|
|
Insulin (human)
|
重组人胰岛素
|
11061-68-0
|
|
PKI(5-24)
|
THR-THR-TYR-ALA-ASP-PHE-ILE-ALA-SER-GLY-ARG-THR-GLY-ARG-ARG-ASN-ALA-ILE-HIS-ASP
|
99534-03-9
|
|
Kemptide
|
肯普肽
|
65189-71-1
|
|
Insulin(cattle)
|
牛胰岛素
|
11070-73-8
|
|
PKI 14-22 amide,myristoylated
|
PKI 14-22 AMIDE, MYRISTOYLATED
|
201422-03-9
|
|
CREBtide
|
多肽CREBtide
|
149155-45-3
|
|
GIP (3-42), human
|
GIP (3 - 42), human
|
1802086-25-4
|
|
MK-8033
|
MK-8033
|
1001917-37-8
|
|
MK-8033 hydrochloride
|
3-(1-甲基-1H-吡唑-4-基)-5-氧代-N-(2-吡啶基甲基)-5H-苯并[4,5]环庚三烯并[1,2-B]吡啶-7-甲烷磺酰胺盐酸盐
|
1283000-43-0
|
|
CP-547632
|
3-[(4-溴-2,6-二氟苄基)氧基]-5-[3-[4-(吡咯烷-1-基)丁基]脲基]异噻唑-4-甲酰胺
|
252003-65-9
|
|
CP-547632 hydrochloride
|
CP-547632 (hydrochloride)
|
252003-71-7
|
|
BAY-474
|
化合物BAY-474
|
1033767-86-0
|
|
Infigratinib phosphate
|
NVP BGJ398 磷酸盐
|
1310746-10-1
|
|
RET-IN-3
|
化合物 RET-IN-3
|
2414374-53-9
|
|
LDN-192960
|
3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺
|
184582-62-5
|
|
LDN-192960 hydrochloride
|
LDN-192960 HYDROCHLORIDE
|
2309172-48-1
|
|
AC710
|
N-[4-[[[[5-(叔丁基)-3-异恶唑基]氨基]羰基]氨基]苯基]-5-[(1-乙基-2,2,6,6-四甲基-4-哌啶基)氧基]-2-吡啶甲酰胺
|
1351522-04-7
|
|
Nocodazole
|
诺考达唑
|
31430-18-9
|
|
CH6953755
|
CH6953755
|
2055918-71-1
|
|
CA-4948
|
4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-
|
1801344-14-8
|
|
AZM475271
|
476159-98-5
|
476159-98-5
|
|
I-OMe-Tyrphostin AG 538
|
I-OME-AG 538
|
1094048-77-7
|
|
BO-264
|
BO-264
|
2408648-20-2
|
|
DCC-3014
|
DCC3014
|
1628606-05-2
|
|
RET V804M-IN-1
|
化合物RET V804M-IN-1
|
2414909-94-5
|
|
PLX647
|
10MG
|
873786-09-5
|
|
Flumatinib mesylate
|
甲磺酸氟马替尼/氟马替尼
|
895519-91-2
|
|
1-Naphthyl PP1 hydrochloride
|
1-叔丁基-3-(1-萘基)-1H-吡唑并[3,4-D]嘧啶-4-胺盐酸盐
|
956025-47-1
|
|
DDR1-IN-1
|
N-[3-[(2,3-二氢-2-氧代-1H-吲哚-5-基)氧基]-4-甲基苯基]-4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯甲酰胺
|
1449685-96-4
|
|
PF-03814735
|
N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺
|
942487-16-3
|
|
BAY 61-3606 dihydrochloride
|
BAY 61-3606
|
648903-57-5
|
|
PRT062607 Hydrochloride
|
PRT062607 (HYDROCHLORIDE)
|
1370261-97-4
|
|
ALK inhibitor 1
|
2-[[5-溴-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺
|
761436-81-1
|
|
ALK inhibitor 2
|
2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺
|
761438-38-4
|
|
Lucitanib
|
德立替尼
|
1058137-23-7
|
|
GDC-0834
|
CS-1263
|
1133432-49-1
|
|
GDC-0834 Racemate
|
N-[3-[6-[[4-(1,4-二甲基-3-氧代-2-哌嗪基)苯基]氨基]-4,5-二氢-4-甲基-5-氧代-2-吡嗪基]-2-甲基苯基]-4,5,6,7-四氢苯并[B]噻吩-2-甲酰胺
|
1133432-46-8
|
|
GDC-0834 S-enantiomer
|
化合物 T11378
|
1133432-50-4
|
|
Imatinib
|
伊马替尼
|
152459-95-5
|
|
Imatinib D8
|
伊马替尼D8
|
1092942-82-9
|
|
VC-4718
|
PND1186
|
1061353-68-1
|